Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Cancer Biotherapy & Radiopharmaceuticals|August 13, 2011
Improved tumor-to-organ ratios of a novel 67Ga-human epidermal growth factor radionuclide conjugate with preadministered antiepidermal growth factor receptor affibody moleculesKarl Sandström, Anna-Karin Haylock, Irina Velikyan, et al.International Journal of Oncology|October 8, 2005
An aminoacridine derivative for radionuclide therapy: DNA binding properties studied in a novel cell-free in vitro assayErika Bohl Kullberg, Bo Stenerlöw, Senait Ghirmai, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 2014
Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantificationIrina Velikyan, Anders Sundin, Jens Sörensen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 10, 2013
Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumorsMattias Sandström, Irina Velikyan, Ulrike Garske-Román, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2013
Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting affibody molecule-albumin-binding domain fusion proteinAnna Orlova, Andreas Jonsson, Daniel Rosik, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 11, 2012
Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatmentMattias Sandström, Ulrike Garske-Román, Dan Granberg, et al.Cancer Research|March 17, 2007
Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody moleculeVladimir Tolmachev, Anna Orlova, Rikard Pehrson, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 3, 2018
Prospective observational study of <sup>177</sup>Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicityUlrike Garske-Román, Mattias Sandström, Katarzyna Fröss Baron, et al.Molecular Cancer Therapeutics|February 20, 2025
Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer XenograftsAnja Charlotte Lundgren Mortensen, Hanna Berglund, Preeti Jha, et al.Global Change Biology|August 23, 2013
Basin-scale phenology and effects of climate variability on global timing of initial seaward migration of Atlantic salmon (Salmo salar)Jaime Otero, Jan Henning L'Abée-Lund, Ted Castro-Santos, et al.Pageof 5